The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Growth In Market Value Is Anticipated For The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Between 2026 And 2030?
The investigational new drug contract development and manufacturing organization (cdmo) market size has demonstrated significant expansion in recent years. It is forecast to increase from $5.91 billion in 2025 to $6.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. The growth observed in the historic period can be linked to the limited availability of CDMOs for investigational drugs, an increasing demand for small molecule synthesis, reliance on conventional manufacturing services, rising clinical trial volumes, and the early adoption of regulatory support services.
The investigational new drug contract development and manufacturing organization (CDMO) market is poised for substantial growth in the upcoming years. It is anticipated to expand to $8.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. This expansion during the forecast period is attributed to factors such as the broadening of gene and cell therapy manufacturing capabilities, a heightened demand for monoclonal antibodies and recombinant proteins, increased investment in advanced formulation technologies, the widespread adoption of scalable manufacturing platforms, and a rise in global biotechnology research collaborations. Key trends expected in the same period include a surging demand for early-stage drug development services, an increase in clinical trial material supply services, a stronger emphasis on regulatory compliance and quality standards, the ongoing development and expansion of biologics and advanced therapies, and the uptake of custom manufacturing solutions for both small and large molecules.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25803&type=smp
Which Drivers Are Advancing The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Growth?
The increasing number of clinical trials is projected to fuel the expansion of the investigational new drug contract development and manufacturing organization (CDMO) market moving forward. These trials are meticulously designed studies involving human subjects, conducted to evaluate the safety and effectiveness of a medical treatment, procedure, or intervention under controlled settings. The escalation in clinical trials is primarily driven by an increasing demand for innovative treatments, as the growing prevalence of chronic and complex diseases prompts pharmaceutical and biotech companies to develop and test new therapies. Investigational new drug CDMOs facilitate clinical trials by streamlining the development and manufacturing of drug formulations ready for trials, thus ensuring a timely and compliant provision of investigational products for each stage of the study. For instance, in December 2024, data from the Association of the British Pharmaceutical Industry, a UK-based pharmaceutical industry trade association, indicated that the total count of industry-sponsored clinical trials launched in the United Kingdom climbed from 411 in 2022 to 426 in 2023, while Phase III trial initiations saw a growth of 16.5 percent over the same period, increasing from 182 to 212. Therefore, the proliferation of clinical trials is propelling the growth of the investigational new drug contract development and manufacturing organization (CDMO) market.
How Does Segment Analysis Break Down The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Structure?
The investigational new drug contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product: Small Molecules, Large Molecules
2) By Formulation Type: Solid Formulations, Liquid Formulations, Injectable Formulations
3) By Service Type: Clinical Trial Material Supply, Regulatory Support Services, Manufacturing Services
4) By End-User: Biotechnology Companies, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Small Molecules: Synthetic Small Molecules, Semi-synthetic Small Molecules, Peptide-based Small Molecules, Oligonucleotides
2) By Large Molecules: Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Cell Therapy Products, Gene Therapy Products, RNA-based Therapeutics
What Trends Are Influencing The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Outlook?
Companies operating within the investigational new drug contract development and manufacturing organization (CDMO) market are increasingly focusing on strategic collaborations to bolster their development capabilities and accelerate their journey into clinical stages. These strategic partnerships involve formal alliances between two or more organizations that work together to achieve common objectives, leveraging each other’s strengths, resources, or specialized knowledge to secure mutual benefits while still operating as independent entities. For example, in August 2023, Sartorius AG, a German life science company, teamed up with Repligen Corporation, a US-based life sciences company, to launch an integrated system that combines BIOSTAT STR and XCell ATF technologies for upstream process intensification. This joint effort aims to optimize biopharmaceutical production by improving efficiency and scalability. The initiative demonstrates Sartorius’ ongoing commitment to innovation in bioprocessing solutions, further solidifying its dedication to advancing the biomanufacturing industry.
Which Key Players Are Active In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the investigational new drug contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Fresenius Kabi AG, Lonza Group Ltd., Catalent Inc., Samsung Biologics Co. Ltd., Fareva SA, Recipharm AB, PCI Pharma Services, Vetter Pharma, Delpharm, Kindeva Drug Delivery LP, Ajinomoto Bio-Pharma Services, Cenexi SAS, Grand River Aseptic Manufacturing Inc., INCOG BioPharma Services, Aurigene Pharmaceutical Services, Jubilant HollisterStier LLC, Symbiosis Pharmaceutical Services Ltd., Afton Scientific Corp., Amaran Biotech Inc.
Access The Complete Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Report:
Which Region Holds The Largest Share In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
North America was the largest region in the investigational new drug contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the investigational new drug contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=25803&type=smp
Browse Through More Reports Similar to the Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model